FDA Watching India Pharmaceuticals With a Closer Eye

Pharmaceutical companies in India have been subject to more scrutiny and oversight by the U.S. Food and Drug Administration due to recent events of bad practice at a handful of facilities, according to a report by The New York Times.

Advertisement

Read the full story on Becker’s Hospital Review.

More Articles on Pharmaceuticals:

Salix Pharmaceuticals Acquires Santarus
Abrams Royal Pharmacy Issues Voluntary Recall on All Unexpired Sterile Products
Valeant Pharmaceuticals International to Acquire Solta Medical for $250M 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.